Landos Biopharma Inc.

NASDAQ: LABP · Real-Time Price · USD
22.93
0.13 (0.57%)
At close: May 23, 2024, 10:00 PM

Landos Biopharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-21.93M -39.28M -38.42M
Depreciation & Amortization
44K 577K 196K
Stock-Based Compensation
971K 1.97M 4.12M
Other Working Capital
2.57M -601K 1.63M
Other Non-Cash Items
-2.13M 1.03M 1.16M
Deferred Income Tax
2.13M n/a n/a
Change in Working Capital
443K -10.07M 5.89M
Operating Cash Flow
-20.48M -45.77M -27.06M
Capital Expenditures
n/a -7K -440K
Cash Acquisitions
n/a 236K -235K
Purchase of Investments
n/a -3.67M -174.85M
Sales Maturities Of Investments
7.78M 77.5M 116.59M
Other Investing Acitivies
-57K n/a 235K
Investing Cash Flow
7.78M 74.06M -58.71M
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
-3M n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
13.57M n/a 91.61M
Financial Cash Flow
13.57M n/a 91.61M
Net Cash Flow
909K 28.34M 5.89M
Free Cash Flow
-20.48M -45.78M -27.5M